BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 27, 2017
View Archived Issues
Fusion Pharmaceuticals launches with series A financing to develop targeted radiotherapeutics
Read More
JCR plans to begin development of JR-162 to treat Pompe disease
Read More
FDA grants approval to initiate phase II study of saroglitazar in patients with PBC
Read More
Xynomic Pharmaceuticals acquires rights to abexinostat
Read More
Phase III study of fusidic acid achieves primary endpoint in patients with ABSSSI
Read More
EMA committee supports conditional marketing approval for Shire's Natpar
Read More
FDA grants fast track designation to Auris Medical's AM-111
Read More
EMA CHMP gives positive opinion on ZS-9 for hyperkalemia
Read More
Tafinlar plus Mekinist granted positive opinion in E.U. for BRAF-positive NSCLC
Read More
EMA committee recommends broadening approval of Darzalex
Read More
NDA resubmitted for latanoprostene bunod
Read More
TroVax treatment shows benefit in advanced colorectal cancer
Read More
MIODx and UCSF enter exclusive license agreement for two key immunotherapy technologies
Read More
EMA committee hands down positive opinion for Varuby
Read More
YKL-40 protein associated with neuronal damage in HIV-infected patients
Read More
Recordati signs licensing agreement with Meyer Hospital for retinopathy of prematurity treatment
Read More
Forty percent response rate seen with ImmunoPulse and pembrolizumab in resistant melanoma patients
Read More
Janssen patents free fatty acid receptor 1 agonists
Read More
Pfizer describes novel IRAK-4 inhibitors
Read More
NORD awards research grants to fund rare disease research
Read More
Roche describes new beta-secretase 1 inhibitors
Read More
Sunshine Lake Pharma synthesizes new 5-HT reuptake inhibitors and/or 5-HT1A receptor agonists
Read More
ViiV Healthcare patents HIV integrase inhibitors
Read More
The Broad Institute, Bayer Pharma identify novel EZH2 inhibitors
Read More
Seed extract DHP-1401 potentiates hippocampal synaptic transmission
Read More
EC approves Revlimid in new indication
Read More